Bluebird: A Hot Biotech IPO Lacking Human Clinical Data

twocents@thestreet.com (David Sobek) — Wed, 19 Jun 2013 15:08:00 GMT

Assessing the risk and rewards of a new biotech company that hasn't yet tested its drugs in real patients.

Click to view a price quote on BLUE.

Apple TV Gets a Major Upgrade

twocents@thestreet.com (Chris Ciaccia) — Wed, 19 Jun 2013 14:32:00 GMT

Apple announced that HBO Go and WatchESPN would be coming to the Apple TV. That's a major upgrade

Click to view a price quote on AAPL.

Click to research the Consumer Durables industry.

Stocks Trade Sideways, All Eyes on Fed; Adobe Surges

twocents@thestreet.com (Andrea Tse) — Wed, 19 Jun 2013 14:31:00 GMT

Stocks were little changed as investors stay on sidelines awaiting information on the Fed's monetary plans.

Click to view a price quote on ^DJI.

5 Housing Markets Where You'll Break Even Fast When You Buy

twocents@thestreet.com (Jerry Kronenberg) — Wed, 19 Jun 2013 14:23:00 GMT

Buying a home seemed too risky to many for a long time, but here are markets where you'd be crazy to rent.

Click to view a price quote on Z.

Click to research the Real Estate industry.

5 Stocks the Pros Love This Summer

twocents@thestreet.com (Jonas Elmerraji) — Wed, 19 Jun 2013 14:14:00 GMT

Fund managers are being selective, but they're buying again in 2013 -- even if it's not with both hands just yet.

Click to view a price quote on BLK.

Click to research the Financial Services industry.

Sprint Takes Game 7 Lead in Dish Battle

twocents@thestreet.com (Antoine Gara) — Wed, 19 Jun 2013 13:55:00 GMT

Sprint and SoftBank may beat a game-clock on wireless merger efforts.

Click to view a price quote on S.

Click to research the Telecommunications industry.

Sarepta's Eteplirsen Walk-A-Thon Now Stretches for 84 Weeks

twocents@thestreet.com (Adam Feuerstein) — Wed, 19 Jun 2013 13:43:00 GMT

Updated results from Sarepta's eteplirsen trial show DMD boys continue to walk.

Click to view a price quote on SRPT.

Click to research the Drugs industry.

AGNC Dividend Ain't So Bad

twocents@thestreet.com (Dan Freed) — Wed, 19 Jun 2013 13:21:00 GMT

Shares aim higher as analysts predicts snap back trade.

Click to view a price quote on AGNC.

Click to research the Real Estate industry.

Tesla Drops on Partial Model S Recall

twocents@thestreet.com (Chris Ciaccia) — Wed, 19 Jun 2013 12:12:00 GMT

Tesla will be recalling some versions of the Model S because of a faulty mounting bracket.

Click to view a price quote on TSLA.

Click to research the Automotive industry.

Vanda's Sleep Disorder Drug Is a Nightmare

twocents@thestreet.com (Adam Feuerstein) — Wed, 19 Jun 2013 11:00:00 GMT

FDA approval of tasimelteon is unlikely because Vanda changed the study design and mis-enrolled patients.

Click to view a price quote on VNDA.

Click to research the Drugs industry.

Stocks Move Higher as Fed Anticipation Mounts

twocents@thestreet.com (Andrea Tse) — Tue, 18 Jun 2013 14:43:00 GMT

Investors remain cautious in anticipation of the Fed's guidance on its asset purchase program and macroeconomic conditions.

Click to view a price quote on ^DJI.

Apple iWatch: Perception Is Reality

twocents@thestreet.com (Chris Ciaccia) — Tue, 18 Jun 2013 13:57:00 GMT

A smart watch would not change Apple's fortunes drastically, but it would alter the perception it has stopped innovating.

Click to view a price quote on AAPL.

Click to research the Consumer Durables industry.

HP Reshuffles Printing Leadership

twocents@thestreet.com (James Rogers) — Tue, 18 Jun 2013 13:46:00 GMT

HP reshuffles the leadership of its key Printing and Personal Systems group.

Click to view a price quote on HPQ.

Click to research the Computer Hardware industry.

Employers: Entry-Level Applicants Are Just About Useless

twocents@thestreet.com (Brian O'Connell) — Tue, 18 Jun 2013 13:00:00 GMT

They lack the job skills and have no clue what soft skills are needed, but they don't know it, a survey finds.

Fed Tapering Bad for Bank Stocks: Bank of America

twocents@thestreet.com (Dan Freed) — Tue, 18 Jun 2013 12:47:00 GMT

Citigroup, PNC, Huntington Bancshares, and JPMorgan are touted as 'cheap defensives.'

Click to view a price quote on C.

Click to research the Banking industry.

3D Printing: Metals The Next Frontier

twocents@thestreet.com (Chris Ciaccia) — Tue, 18 Jun 2013 12:43:00 GMT

Following the company's analyst day, Canaccord Genuity raised its price target on 3D Systems, citing a move into the metal space.

Click to view a price quote on DDD.

Click to research the Industrial industry.

Delta, JetBlue Lead Airline Service Rankings, Survey Says

twocents@thestreet.com (Ted Reed) — Tue, 18 Jun 2013 10:25:00 GMT

Delta has the most satisfaction service among legacy carriers, while JetBlue leads all carriers, according to a consumer survey.

Click to view a price quote on DAL.

Click to research the Transportation industry.

Five Stocks for Your Kid's Portfolio

twocents@thestreet.com (Bret Kenwell) — Tue, 18 Jun 2013 10:00:00 GMT

You're never too young to begin investing. These stocks are names your kids will recognize.

Click to view a price quote on DIS.

Click to research the Media industry.

'Mad Money' Lightning Round: ConAgra Is Terrific

twocents@thestreet.com (Scott Rutt) — Tue, 18 Jun 2013 10:00:00 GMT

Cramer likes Tupperware and Pier 1 but wonders why anyone would buy Sears.

Click to view a price quote on EBAY.

Click to research the Retail industry.

Coal Is First Casualty of Energy Abundance

twocents@thestreet.com (Dana Blankenhorn) — Tue, 18 Jun 2013 10:00:00 GMT

The coal industry is in a death spiral, squeezed between its own carbon costs and profitable alternatives.

Click to view a price quote on BHP.

Click to research the Metals & Mining industry.

Stocks Leap at Open on Manufacturing Gains

twocents@thestreet.com (Andrea Tse) — Mon, 17 Jun 2013 14:39:00 GMT

Major U.S. stock markets rise Monday on reassuring U.S. economic reports.

Click to view a price quote on ^DJI.

Lowe's Bids for Orchard Supply

twocents@thestreet.com (Brittany Umar) — Mon, 17 Jun 2013 14:09:00 GMT

Lowe's offers to buy Orchard Supply Hardware Stores for about $205 million in cash.

Click to view a price quote on LOW.

Click to research the Retail industry.

J&J Buy of Aragon Deals a Blow to Medivation

twocents@thestreet.com (Pieter Droppert) — Mon, 17 Jun 2013 13:57:00 GMT

Medivation now has a formidable competitor for prostate cancer therapy.

Click to view a price quote on JNJ.

Click to research the Drugs industry.

Moody's Disagrees on MetLife 'Shadow Insurance' Risk

twocents@thestreet.com (Antoine Gara) — Mon, 17 Jun 2013 13:56:00 GMT

Moody's sees a ratings benefit if New York firms end 'shadow insurance.'

Click to view a price quote on MET.

Click to research the Insurance industry.

Intel's Next Trick May Be Octa-Core Processors

twocents@thestreet.com (Gary Krakow) — Mon, 17 Jun 2013 13:56:00 GMT

Next year's Intel Haswell-E chips are rumored to contain at least six and as many as eight processing cores.

Click to view a price quote on INTC.

Click to research the Electronics industry.

Top Read Stories

Bluebird: A Hot Biotech IPO Lacking Human Clinical Data

Apple TV Gets a Major Upgrade

Stocks Trade Sideways, All Eyes on Fed; Adobe Surges

5 Housing Markets Where You'll Break Even Fast When You Buy

5 Stocks the Pros Love This Summer

Sprint Takes Game 7 Lead in Dish Battle

Sarepta's Eteplirsen Walk-A-Thon Now Stretches for 84 Weeks

AGNC Dividend Ain't So Bad

Tesla Drops on Partial Model S Recall

Vanda's Sleep Disorder Drug Is a Nightmare

Stocks Move Higher as Fed Anticipation Mounts

Apple iWatch: Perception Is Reality

HP Reshuffles Printing Leadership

Employers: Entry-Level Applicants Are Just About Useless

Fed Tapering Bad for Bank Stocks: Bank of America

3D Printing: Metals The Next Frontier

Delta, JetBlue Lead Airline Service Rankings, Survey Says

Five Stocks for Your Kid's Portfolio

'Mad Money' Lightning Round: ConAgra Is Terrific

Coal Is First Casualty of Energy Abundance

Stocks Leap at Open on Manufacturing Gains

Lowe's Bids for Orchard Supply

J&J Buy of Aragon Deals a Blow to Medivation

Moody's Disagrees on MetLife 'Shadow Insurance' Risk

Intel's Next Trick May Be Octa-Core Processors